[ Price : $8.95]
Acting FDA commissioner Janet Woodcock describes FDAs current priorities at a Senate appropriations hearing on budget priorities, ...[ Price : $8.95]
Two members of the advisory committee that reviewed data and voted against approving Biogens Alzheimers therapy resign in protest ...[ Price : $8.95]
FDA releases an FDA-483 with four observations from an inspection at the BSO outsourcing facility.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension for New Animal Drugs for Investigational Use 21 CFR...[ Price : $8.95]
Acer Therapeutics plans to submit an IND and protocol for a pivotal study of its Edsivo to treat patients with COL3A1+ vascular Eh...[ Price : $8.95]
Federal Register notice: FDA corrects a document that appeared in the 3/11/2020 Federal Register that announced the agency will be...[ Price : $8.95]
FDA approves Medtronics Vanta recharge-free implantable neurostimulator.[ Price : $8.95]
FDA releases the FDA-483 issued following 2019 inspections of two trial investigators at the Hennepin County Medical Center.